BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28232469)

  • 1. Molecular features of early onset adult myelodysplastic syndrome.
    Hirsch CM; Przychodzen BP; Radivoyevitch T; Patel B; Thota S; Clemente MJ; Nagata Y; LaFramboise T; Carraway HE; Nazha A; Sekeres MA; Makishima H; Maciejewski JP
    Haematologica; 2017 Jun; 102(6):1028-1034. PubMed ID: 28255022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms.
    Wiśniewska-Chudy E; Szylberg Ł; Dworacki G; Mizera-Nyczak E; Marszałek A
    Oncol Rep; 2017 Apr; 37(4):2295-2307. PubMed ID: 28260027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.
    Schnöder TM; Eberhardt J; Koehler M; Bierhoff HB; Weinert S; Pandey AD; Nimmagadda SC; Wolleschak D; Jöhrens K; Fischer T; Heidel FH
    J Cancer Res Clin Oncol; 2017 May; 143(5):807-820. PubMed ID: 28233092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
    Nassani R; Bokhari Y; Alrfaei BM
    PLoS One; 2023; 18(11):e0287448. PubMed ID: 37972206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Spatial MIST for Versatile, Scalable Detection of Protein Markers.
    Meah A; Vedarethinam V; Bronstein R; Gujarati N; Jain T; Mallipattu SK; Li Y; Wang J
    Biosensors (Basel); 2023 Aug; 13(9):. PubMed ID: 37754086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer.
    Plasterer C; Semenikhina M; Tsaih SW; Flister MJ; Palygin O
    Mol Med; 2023 Jul; 29(1):87. PubMed ID: 37400769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-edged sword: role of apoptosis repressor with caspase recruitment domain (ARC) in tumorigenesis and ischaemia/reperfusion (I/R) injury.
    Liu K; Lan D; Li C; Liu S; Dai X; Song T; Wang X; Kong Q; He Z; Tan J; Zhang J
    Apoptosis; 2023 Apr; 28(3-4):313-325. PubMed ID: 36652128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and construction of prognostic model for clear cell renal cell carcinoma based on single-cell and bulk transcriptome analysis.
    Zhang F; Yu S; Wu P; Liu L; Wei D; Li S
    Transl Androl Urol; 2021 Sep; 10(9):3540-3554. PubMed ID: 34733651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic antitumour effect of multi-components from
    Guan Z; Chen L; Zhou Y; Luo Y; Cui Y; Liu R; Shou B
    Pharm Biol; 2020 Dec; 58(1):427-437. PubMed ID: 32476531
    [No Abstract]   [Full Text] [Related]  

  • 10. Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of Lung Cancer.
    Pan J; Yu L; Wu Q; Lin X; Liu S; Hu S; Rosa C; Eichinger D; Pino I; Zhu H; Qian J; Huang Y
    Mol Cell Proteomics; 2020 Mar; 19(3):490-500. PubMed ID: 31924693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
    Kleppe M; Kwak M; Koppikar P; Riester M; Keller M; Bastian L; Hricik T; Bhagwat N; McKenney AS; Papalexi E; Abdel-Wahab O; Rampal R; Marubayashi S; Chen JJ; Romanet V; Fridman JS; Bromberg J; Teruya-Feldstein J; Murakami M; Radimerski T; Michor F; Fan R; Levine RL
    Cancer Discov; 2015 Mar; 5(3):316-31. PubMed ID: 25572172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecularly pathogenesis and molecular targeted therapy for myeloproliferative neoplasms].
    Shide K
    Rinsho Ketsueki; 2015 Feb; 56(2):150-8. PubMed ID: 25765794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Mosca M; Vertenoeil G; Toppaldoddi KR; Plo I; Vainchenker W
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S16-28. PubMed ID: 27494969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A myeloid tumor suppressor role for
    Stanley RF; Piszczatowski RT; Bartholdy B; Mitchell K; McKimpson WM; Narayanagari S; Walter D; Todorova TI; Hirsch C; Makishima H; Will B; McMahon C; Gritsman K; Maciejewski JP; Kitsis RN; Steidl U
    J Exp Med; 2017 Mar; 214(3):753-771. PubMed ID: 28232469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-specific loss of
    Chorzalska A; Morgan J; Ahsan N; Treaba DO; Olszewski AJ; Petersen M; Kingston N; Cheng Y; Lombardo K; Schorl C; Yu X; Zini R; Pacilli A; Tepper A; Coburn J; Hryniewicz-Jankowska A; Zhao TC; Oancea E; Reagan JL; Liang O; Kotula L; Quesenberry PJ; Gruppuso PA; Manfredini R; Vannucchi AM; Dubielecka PM
    Blood; 2018 Nov; 132(19):2053-2066. PubMed ID: 30213875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.